DOI: 10.13140/RG.2.1.2908.0486
Epigraph
Changing medical professional conducting intravitreal injection of anti-angiogenic medication should not provide harm to patients if technical, organizational, ethical and scientific criteria are followed strictly. The risks inherent in the procedure should remain the same regardless of the attending physician.
Full content in Portuguese
Adicionar Comentário